Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetic Nephropathy: A Review of Clinical Effectiveness (Last Updated: Sep 20, 2019)
Project Line:
Health Technology Review
Current Filters
Diabetes Virtual Library Remove
Hybrid Closed Loop Insulin Delivery Systems: Clinical Effectiveness (Last Updated: Sep 17, 2019)
Project Line:
Reference List
glucagon (Baqsimi) (Last Updated: Mar 17, 2020)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Baqsimi
Manufacturer:
Eli Lilly Canada Inc.
Submission Type:
Initial
Indications:
Severe hypoglycemic reactions
Wearables with Neuroreceptor Activation Patterns for Foot Neuropathy or Musculoskeletal Foot or Back Pain: Clinical Effectiveness (Last Updated: Aug 27, 2019)
Project Line:
Reference List
Post-Partum Screening and Monitoring for Gestational Diabetes: Clinical Effectiveness and Guidelines (Last Updated: Aug 28, 2018)
Project Line:
Reference List
Foot Care Interventions for Adults in the Community Setting: Clinical Effectiveness and Guidelines (Last Updated: Jul 20, 2018)
Project Line:
Reference List
Management of Diabetes in Long-Term Care Facilities: Guidelines (Last Updated: Jun 28, 2018)
Project Line:
Reference List
insulin degludec + liraglutide (Xultophy) (Last Updated: Jun 18, 2020)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Xultophy
Manufacturer:
Novo Nordisk Canada Inc.
Submission Type:
Initial
Indications:
Diabetes mellitus, Type 2
lixisenatide + insulin glargine (Soliqua) (Last Updated: Jan 30, 2019)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Soliqua
Manufacturer:
sanofi-aventis Canada Inc.
Submission Type:
Initial
Indications:
Diabetes mellitus, Type 2
ertugliflozin and metformin (Segluromet) (Last Updated: Feb 7, 2019)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indications
Brand Name:
Segluromet
Manufacturer:
Merck Canada Inc.
Submission Type:
Initial
Indications:
Diabetes mellitus, Type 2